Arch Pharmalabs
BSE: 524729 | NSE: N.A | ISIN: INE182F01017 | Pharmaceuticals
 |
 |
Quarterly Results of Arch Pharmalabs |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Dec '04 | Mar '05 | Jun '05 | Sep '05 | Dec '05 | ||||||
|
||||||||||
| Sales Turnover | 42.38 | 39.67 | 45.00 | 58.26 | 66.49 | |||||
| Other Income | 0.09 | 0.10 | 0.08 | 0.16 | 0.13 | |||||
| Total Income | 42.46 | 39.77 | 45.07 | 58.42 | 66.62 | |||||
| Total Expenses | 34.44 | 32.83 | 35.50 | 47.37 | 53.79 | |||||
| Operating Profit | 7.94 | 6.84 | 9.50 | 10.89 | 12.70 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 8.03 | 6.94 | 9.58 | 11.05 | 12.83 | |||||
| Interest | 2.54 | 3.33 | 2.99 | 3.51 | 4.44 | |||||
| PBDT | 5.49 | 3.62 | 6.58 | 7.54 | 8.39 | |||||
| Depreciation | 0.93 | 1.15 | 1.80 | 2.29 | 2.51 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 4.56 | 2.47 | 4.78 | 5.25 | 5.88 | |||||
| Tax | 1.25 | 0.90 | 1.30 | 1.45 | 1.50 | |||||
| Net Profit | 3.31 | 1.57 | 3.48 | 3.80 | 4.38 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 3.55 | 1.19 | 2.64 | 2.78 | 3.20 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 9.30 | 13.17 | 13.17 | 13.69 | 13.69 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Arch Pharmalabs connections | ||||||||||
| ||||||||||
